leisure time -WSS

leisure time

author：focus 2025-09-28 21:11:21 - browse：57

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Novo Nordisk touts Wegovy study, but still struggling with supply

WSS

Bernie Sanders gets little from pharma CEOs on drug prices

Biogen’s boardroom scandal saddles CEO with first crisis

Patients, digital health players weigh in on FTC's data privacy plan

Patients, digital health players weigh in on FTC's data privacy plan

BMS, looking to build heart drug business, turns to AI for diagnosis

Judge sides with young activists in first

knowledge

leisure time

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Patients, digital health players weigh in on FTC's data privacy plan

BioMarin wins approval for gene therapy to treat hemophilia A

Why Eli Lilly’s earnings didn’t quite live up to the hype

Trump demands the U.S. pay no more for drugs than other countries … again

Megan Rapinoe shares emotional post following US Women's World Cup exit

Activists slam private health insurers over coverage restrictions

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Wildfire smoke exposes gaps in outdoor worker protections

Maui wildfire now ranks as the fifth

explore

Maui wildfire now ranks as the fifth

Report cites 'urgent' need to recruit more diverse clinical trial participants

Study gives hint on South Asians’ higher risk of cardiovascular disease

Too many hospitalized Covid

Biden administration begins canceling student loan debt for 804,000 borrowers

Megan Rapinoe shares emotional post following US Women's World Cup exit

leisure time

focus

entertainment

explore